Delisting riskPopularity #3,931
HYPR · NASDAQ · Medical - Devices

Hyperfine (HYPR)

Makes and supports Swoop, a portable ultra-low-field brain-MRI system.

$0.8200
After hours+0.01 (+1.31%)
At close$0.8094(+3.62%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue233442233544
Cost of revenue122221112322
Gross profit111221112322
131312131312121111101110
Research & development666665554444
776776767777
Selling & marketing332222333333
General & administrative544454444444
Operating income−12−12−11−11−11−11−11−10−9−8−9−8
11111010−220−1
Interest income111110000000
Interest expense000000000001
Other non-operating income0−1−1−1−10−102−200
Income before tax−11−11−10−10−10−10−9−9−11−6−9−9
Net income from continuing operations−11−11−10−10−10−10−9−9−11−6−9−9
Net income−11−11−10−10−10−10−9−9−11−6−9−9
EPS, basic−$0.15−$0.15−$0.14−$0.14−$0.14−$0.14−$0.12−$0.12−$0.14−$0.06−$0.09−$0.09
EPS, diluted−$0.15−$0.15−$0.14−$0.14−$0.14−$0.14−$0.12−$0.12−$0.14−$0.06−$0.09−$0.09
Weighted average shares, basic7172727273737678799498100
Weighted average shares, diluted7172727273737678799498100
EBITDA−11−10−10−10−10−10−9−9−11−5−8−8
Depreciation & amortization000000000101
EBIT−12−11−10−10−10−10−9−9−11−6−9−9